Literature DB >> 15707919

Effect of hypercholesterolemia on inducible nitric oxide synthase expression in a rat model of elevated intraocular pressure.

Iclal Yücel1, Yusuf Akar, Gültekin Yücel, M Akif Ciftçioğlu, Nuran Keleş, Mutay Aslan.   

Abstract

PURPOSE: This study was performed to examine the effect of hypercholesterolemia on inducible nitric oxide synthase (NOS-2) expression and oxidative tissue injury in an experimental rat model of elevated IOP.
METHODS: Wistar rats were maintained on either regular chow or a high-cholesterol diet for 24 weeks. Intraocular pressure (IOP) was elevated in hypercholesterolemic rats by unilaterally cauterizing three episcleral vessels. Rats were divided into four experimental groups as follows; hypercholesterolemia, hypercholesterolemia+elevated IOP, elevated IOP and control. NOS-2 distribution, lipid peroxidation and retinal nerve fiber layer (RNFL) thickness was evaluated in all experimental groups at the end of 24 weeks.
RESULTS: Light microscopic evaluation of retinas in hypercholesterolemic rats revealed breaks and discontinuation in focal areas in the outer nuclear layer (ONL). NOS-2 positive staining was observed throughout the outer plexiform layer (OPL), inner plexiform layer (IPL) and ganglion cell layer (GCL) in rats with elevated IOP and/or hypercholesterolemia. Calculated values of RNFL thickness in hypercholesterolemic rats were significantly higher than those in the control and elevated IOP group. Vitreous malondialdehyde (MDA) levels detected in elevated IOP (3.51+/-0.31 nmol/mg protein) and hypercholesterolemia+elevated IOP (5.14+/-1.28 nmol/mg protein) groups were significantly higher than those detected in hypercholesterolemic (1.92+/-1.43 nmol/mg protein) and control (1.89+/-0.24 nmol/mg protein) groups.
CONCLUSION: The presented data confirms hypercholesterolemia as a risk factor in the development of glaucomatous optic neuropathy (GON) and suggests that increased circulating cholesterol may exacerbate disease progression by inducing NOS-2 expression and elevating oxidant tissue injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15707919     DOI: 10.1016/j.visres.2004.11.018

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  12 in total

1.  Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis.

Authors:  Arzu Toruk Aksar; Nursen Yuksel; Mustafa Gok; Mustafa Cekmen; Yusuf Caglar
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

2.  Inducible nitric oxide synthase-mediated alteration of mitochondrial OPA1 expression in ocular hypertensive rats.

Authors:  Yi Dai; Robert N Weinreb; Keun-Young Kim; Duy Nguyen; Sangwoo Park; Xinghuai Sun; James D Lindsey; Mark H Ellisman; Won-Kyu Ju
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-16       Impact factor: 4.799

Review 3.  Oxidative stress and potential applications of free radical scavengers in glaucoma.

Authors:  Mutay Aslan; Serdar Dogan; Ertan Kucuksayan
Journal:  Redox Rep       Date:  2013-03-06       Impact factor: 4.412

4.  Effects on high cholesterol-fed to liver, retina, hippocampus, and Harderian gland in Goto-Kakizaki rat.

Authors:  Kanchana Kengkoom; Aekkarin Klinkhamhom; Aunchalee Sirimontaporn; Ornuma Singha; Taweesak Ketjareon; Yaowaluk Panavechkijkul; Dutmanee Seriwatanachai; Suluck Ukong; Sumate Ampawong
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

5.  Inhibition of neutral sphingomyelinase decreases elevated levels of nitrative and oxidative stress markers in liver ischemia-reperfusion injury.

Authors:  Betul Unal; Filiz Ozcan; Hazal Tuzcu; Ebru Kırac; Gulsum O Elpek; Mutay Aslan
Journal:  Redox Rep       Date:  2016-03-24       Impact factor: 4.412

6.  Role of cholesterol 24S-hydroxylase gene polymorphism (rs754203) in primary open angle glaucoma.

Authors:  Georg Mossböck; Martin Weger; Christoph Faschinger; Otto Schmut; Wilfried Renner; Andreas Wedrich; Christina Zimmermann; Yosuf El-Shabrawi
Journal:  Mol Vis       Date:  2011-02-26       Impact factor: 2.367

7.  The evaluation of the oxidative stress parameters in patients with primary angle-closure glaucoma.

Authors:  Dong Chang; Qian Sha; Xuefei Zhang; Peipei Liu; Shengzhong Rong; Tao Han; Ping Liu; Hongzhi Pan
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

8.  Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model.

Authors:  Nagehan Can; Onur Catak; Burak Turgut; Tamer Demir; Nevin Ilhan; Tuncay Kuloglu; Ibrahim Hanifi Ozercan
Journal:  Drug Des Devel Ther       Date:  2015-06-02       Impact factor: 4.162

Review 9.  Lipid peroxidation: pathophysiological and pharmacological implications in the eye.

Authors:  Ya Fatou Njie-Mbye; Madhura Kulkarni-Chitnis; Catherine A Opere; Aaron Barrett; Sunny E Ohia
Journal:  Front Physiol       Date:  2013-12-16       Impact factor: 4.566

10.  Neuroprotective Effects of Low-Dose Statins in the Retinal Ultrastructure of Hypercholesterolemic Rabbits.

Authors:  Judith Fernández-Navarro; Pilar Aldea; Rosa de Hoz; Juan J Salazar; Ana I Ramírez; Blanca Rojas; Beatriz I Gallego; Alberto Triviño; Teresa Tejerina; José M Ramírez
Journal:  PLoS One       Date:  2016-05-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.